Developing bioproduction and its sustainability
Biodrugs and drugs for innovative therapies currently represent 50% of clinical trials in progress and are potential therapeutic solutions for patients.
Ensuring their development and production is a crucial challenge.
Indatech is one of the French actors contributing to bioproduction and its sustainability.
Fabien Chauchard, Managing Director, will be showing how the innovative sensors from Indatech Chauvin Arnoux help to control the processes at all stages in the bioproduction line.